JOINT FILING AGREEMENT

Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Ordinary Share,, $.0001 par value per share, of CASI Pharmaceuticals, Inc., a Cayman corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Dated: August 12, 2023

	ETP GLOBAL FUND L.P.
	By:	EMERGING TECHNOLOGY PARTNERS, LLC General Partner
	By:	/s/ Xxx-Xx Xx, Ph.D.
		Name:	Xxx-Xx Xx, Ph.D.
		Title:	Managing Member

	EMERGING TECHNOLOGY PARTNERS, LLC
	By:	/s/ Xxx-Xx Xx, Ph.D.
		Name:	Xxx-Xx Xx, Ph.D.
		Title:	Managing Member

	ETP-BIOHEALTH FUND III L.P.
	By:	EMERGING TECHNOLOGY PARTNERS, LLC General Partner
	By:	/s/ Xxx-Xx Xx, Ph.D.
		Name:	Xxx-Xx Xx, Ph.D.
		Title:	Managing Member

	HUIYING MEMORIAL FOUNDATION
	By:	/s/ Xxx-Xx Xx, Ph.D.
		Name:	Xxx-Xx Xx, Ph.D.
		Title:	President

	HE Family GRAT
	By:	/s/ Xxx-Xx Xx, Ph.D.
		Name:	Xxx-Xx Xx, Ph.D.
		Title:	Trustee

/s/ Xxx-Xx He, Ph.X.

Xxx-Xx Xx, Ph.D.